We are live on ! Find out more
SS

Steve Schonfeld Schonfeld Strategic Advisors

AUM $27.9B
1-Year Est. Return 51.18%
 

Steve Schonfeld is the founder of Schonfeld Strategic Advisors, a multi-manager investment firm with roots in proprietary trading. Schonfeld allocates capital across quantitative and discretionary strategies with an emphasis on risk controls and diversification of return streams. The firm is a major name in the multi-strategy hedge fund landscape.

This Fund
S&P 500
This Quarter Est. Return
+3.8%
1 Year Est. Return
+51.18%
3 Year Est. Return
+146.2%
5 Year Est. Return
+181.83%
10 Year Est. Return
+1,776.88%
AUM
$22.6B
AUM Growth
+$4.98B
Cap. Flow
+$4.53B
Cap. Flow %
20.05%
Top 10 Hldgs %
40.91%
Holding
2,774
New
620
Increased
589
Reduced
714
Closed
789

Top Buys

Rank Stock Value
1
IVV icon
iShares Core S&P 500 ETF
IVV
+$5.4B
2
NVDA icon
NVIDIA
NVDA
+$388M
3
MSFT icon
Microsoft
MSFT
+$182M
4
AMZN icon
Amazon
AMZN
+$177M
5
GOOG icon
Alphabet (Google) Class C
GOOG
+$163M

Top Sells

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$213M
2
AVGO icon
Broadcom
AVGO
+$103M
3
UNP icon
Union Pacific
UNP
+$100M
4
ETHA
iShares Ethereum Trust ETF
ETHA
+$89.9M
5
MRVL icon
Marvell Technology
MRVL
+$89.4M

Sector Composition

Rank Sector Weight
1 Technology 11.68%
2 Industrials 8.46%
3 Financials 6.55%
4 Consumer Discretionary 5.99%
5 Healthcare 5.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
OBAWW
1926
Oxley Bridge Acquisition Ltd Warrants
OBAWW
$2.23M
$20.9K ﹤0.01%
95,000
+5,000
+6% +$1.24K
MKLYR
1927
McKinley Acquisition Corp Rights
MKLYR
$20.3K ﹤0.01%
+156,578
New +$27.1K
GERN icon
1928
Geron
GERN
$977M
$20.2K ﹤0.01%
15,324
-748,187
-98% -$939K
SOUL.RT
1929
Soulpower Acquisition Corp Rights
SOUL.RT
$19.5K ﹤0.01%
111,305
-141,328
-56% -$27.8K
SDHIR
1930
Siddhi Acquisition Corp Right
SDHIR
$19.3K ﹤0.01%
89,558
-61,053
-41% -$15.9K
PMCB icon
1931
PharmaCyte Biotech
PMCB
$5.64M
$19K ﹤0.01%
26,178
-22
-0.1% -$20
TAVIR
1932
Tavia Acquisition Corp Right
TAVIR
$18.4K ﹤0.01%
80,000
-52,632
-40% -$12.3K
DRDBW
1933
Roman DBDR Acquisition Corp II Warrants
DRDBW
$18.3K ﹤0.01%
30,000
-2,500
-8% -$1.64K
REFR icon
1934
Research Frontiers
REFR
$16.3M
$18.1K ﹤0.01%
13,836
+300
+2% +$507
INACR
1935
Indigo Acquisition Corp Right
INACR
$17.4K ﹤0.01%
120,000
+20,000
+20% +$3.49K
MYPS icon
1936
PLAYSTUDIOS Inc
MYPS
$60.3M
$16.3K ﹤0.01%
25,000
– –
ANTX icon
1937
AN2 Therapeutics
ANTX
$212M
$16.3K ﹤0.01%
14,281
– –
AIFC
1938
AI Financial Corp
AIFC
$92.2M
$16.3K ﹤0.01%
14,796
-1,787
-11% -$3.44K
EVAC.WS
1939
EQV Ventures Acquisition Corp II Warrants
EVAC.WS
$15.7K ﹤0.01%
45,000
+5,000
+13% +$1.78K
LEDS icon
1940
SemiLEDS
LEDS
$15.3M
$15.4K ﹤0.01%
10,277
-99
-1% -$223
LXRX icon
1941
Lexicon Pharmaceuticals
LXRX
$1.03B
$15.1K ﹤0.01%
13,108
-812,525
-98% -$1.12M
VTGN icon
1942
VistaGen Therapeutics
VTGN
$10.8M
$14.4K ﹤0.01%
21,736
+10,853
+100% +$39.2K
EMISR
1943
Emmis Acquisition Corp Rights
EMISR
$13.9K ﹤0.01%
+86,786
New +$13.8K
VACHW
1944
DELISTED
Voyager Acquisition Corp Warrants
VACHW
$13.8K ﹤0.01%
66,444
-21,582
-25% -$4.88K
LPAAW
1945
Launch One Acquisition Corp Warrant
LPAAW
$1.73M
$13.7K ﹤0.01%
54,830
-11,066
-17% -$2.65K
SSEAR
1946
Starry Sea Acquisition Corp Rights
SSEAR
$13.3K ﹤0.01%
+61,793
New +$16K
CHPGR
1947
ChampionsGate Acquisition Corp Rights
CHPGR
$12.8K ﹤0.01%
76,100
-29,953
-28% -$4.96K
NMPAR
1948
NMP Acquisition Corp Right
NMPAR
$12.7K ﹤0.01%
63,460
-940
-1% -$219
CCIIW
1949
Cohen Circle Acquisition Corp II Warrant
CCIIW
$12.6K ﹤0.01%
18,000
-2,000
-10% -$1.55K
PELIR
1950
DELISTED
Pelican Acquisition Corp Right
PELIR
$12K ﹤0.01%
52,264
+2,264
+5% +$603
76 77
78
79 80

Similar funds

UIM
USS Investment Management London, United Kingdom $27.8B AUM 39.42% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return
CM
Capula Management Grand Cayman, Cayman Islands $28B AUM 22.67% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
CAM
Cresset Asset Management Chicago, Illinois $27.6B AUM 31.92% 1-Year Est. Return
Fiera Capital (Canada)
Fiera Capital (Canada) Montreal, Quebec, Canada $27.6B AUM 23.56% 1-Year Est. Return
Los Angeles Capital Management
Los Angeles Capital Management Los Angeles, California $27.2B AUM 43.16% 1-Year Est. Return

Steve Schonfeld's Q4 2025 Portfolio in Review

As of Q4 2025, Steve Schonfeld held 2,774 positions worth $22.6B, up 28% from $17.6B the previous quarter. Its ten largest holdings account for 41% of the portfolio.

Steve Schonfeld deployed $4.53B of net new capital in Q4 2025, opening 620 new positions and adding to 589 existing holdings. Its largest new stake was Medline Inc: 1,945,050 shares worth $81.7M.

By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 14% a quarter earlier, followed by Industrials and Financials.

On the sell side, the largest reduction was Eli Lilly, an estimated $213M trimmed.

  • Steve Schonfeld's largest Q4 2025 buy was Medline Inc: 1,945,050 shares worth $81.7M.
  • Steve Schonfeld added most to iShares Core S&P 500 ETF in Q4 2025, an estimated $5.4B increase.
  • Steve Schonfeld's biggest Q4 2025 reduction was Eli Lilly, cutting an estimated $213M.
  • Steve Schonfeld fully exited Southwest Airlines in Q4 2025, selling an estimated $73.9M.
  • Steve Schonfeld's ten largest holdings make up 41% of its $22.6B portfolio in Q4 2025.
  • Steve Schonfeld opened 620 new positions and closed 789 in Q4 2025.
  • Steve Schonfeld's portfolio value rose 28% quarter-over-quarter to $22.6B.

Based on Schonfeld Strategic Advisors's 13F filing for Q4 2025, filed 17 Feb 2026.